Literature DB >> 2891038

The role of alpha 1- and alpha 2-adrenoceptors in the coronary vasoconstrictor responses to neuronally released and exogenous noradrenaline in the dog.

O L Woodman1.   

Abstract

1. Coronary vasoconstriction was examined in response to the neuronal release of noradrenaline produced by bilateral carotid occlusion and the infusion of tyramine (5-50 micrograms/kg/min i.v.) in anaesthetized dogs which had been vagotomized and treated with the beta-adrenoceptor antagonist propranolol (1.0 mg/kg i.v.). These responses were compared to those produced by the infusion of noradrenaline (0.1-0.5 micrograms/kg/min i.v.). 2. Similar increases in late diastolic coronary resistance were produced by bilateral carotid occlusion (0.70 +/- 0.25 mm Hg min/ml), and intravenous infusions of tyramine, 20 micrograms/kg/min (0.70 +/- 0.12 mm Hg min/ml) and noradrenaline, 0.5 micrograms/kg/min (0.59 +/- 0.11 mm Hg min/ml). 3. Selective antagonism at alpha 1-adrenoceptors with prazosin (0.5 mg/kg i.v.) attenuated the coronary constrictor response to bilateral carotid occlusion (0.36 +/- 0.09 mm Hg min/ml), tyramine (0.12 +/- 0.06 mm Hg min/ml) and noradrenaline (0.18 +/- 0.07 mm Hg min/ml). Antagonism at alpha 2-adrenoceptors with idazoxan (1 mg/kg i.v.) attenuated the coronary vasoconstriction produced by bilateral carotid occlusion (0.30 +/- 0.06 mm Hg min/ml), tyramine (0.17 +/- 0.08 mm Hg min/ml) and noradrenaline (0.12 +/- 0.03 mm Hg min/ml). Combined antagonism at both alpha 1- and alpha 2-adrenoceptors with prazosin and idazoxan abolished the responses to bilateral carotid occlusion, tyramine and noradrenaline. 4. These results show that coronary vasoconstriction produced by either neuronally released or exogenous noradrenaline is mediated by both alpha 1- and alpha 2-adrenoceptors. It appears that in the coronary resistance vessels of the dog postjunctional alpha 1- and alpha 2-adrenoceptors are both innervated by sympathetic nerves.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2891038     DOI: 10.1007/bf00165800

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  37 in total

1.  The mode of action of tyramine.

Authors:  M J DAVEY; J B FARMER
Journal:  J Pharm Pharmacol       Date:  1963-03       Impact factor: 3.765

2.  Release of norepinephrine from the heart by vasoactive amines.

Authors:  C A CHIDSEY; D C HARRISON; E BRAUNWALD
Journal:  Proc Soc Exp Biol Med       Date:  1962-03

3.  Pre- and postsynaptic effects of yohimbine stereoisomers on noradrenergic transmission in the pulmonary artery of the rabbit.

Authors:  R Weitzell; T Tanaka; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-08       Impact factor: 3.000

4.  Sympathetic control of myocardial oxygen balance in dogs mediated by activation of coronary vascular alpha 2-adrenoceptors.

Authors:  M Saeed; J Holtz; D Elsner; E Bassenge
Journal:  J Cardiovasc Pharmacol       Date:  1985 Jan-Feb       Impact factor: 3.105

5.  Influence of drugs with affinity for alpha-adrenoceptors on noradrenaline release by potassium, tyramine and dimethylphenylpiperazinium.

Authors:  K Starke; H Montel
Journal:  Eur J Pharmacol       Date:  1974-08       Impact factor: 4.432

6.  Responsiveness to cardiac sympathetic nerve stimulation during maximal coronary dilation produced by adenosine.

Authors:  U J Johannsen; A L Mark; M L Marcus
Journal:  Circ Res       Date:  1982-04       Impact factor: 17.367

7.  Stimulation of the release of catecholamines from isolated adrenal glands by tyramine.

Authors:  R L Robinson
Journal:  J Pharmacol Exp Ther       Date:  1966-01       Impact factor: 4.030

8.  Types and functions of peripheral alpha-adrenoceptors.

Authors:  K Starke; J R Docherty
Journal:  J Cardiovasc Pharmacol       Date:  1982       Impact factor: 3.105

9.  Further investigation of the sites of vascular alpha 1 and alpha 2 adrenoceptors in the anaesthetised spontaneously hypertensive rat.

Authors:  P Warnock; J R Docherty
Journal:  J Cardiovasc Pharmacol       Date:  1986 Jan-Feb       Impact factor: 3.105

10.  Alpha 1- and alpha 2-adrenoceptor-mediated vasoconstriction of large and small canine coronary arteries in vivo.

Authors:  G Heusch; A Deussen; J Schipke; V Thämer
Journal:  J Cardiovasc Pharmacol       Date:  1984 Sep-Oct       Impact factor: 3.105

View more
  7 in total

1.  Minimal alpha 1- and alpha 2-adrenoceptor-mediated coronary vasoconstriction in the anaesthetized swine.

Authors:  R Schulz; R J Oudiz; B D Guth; G Heusch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-10       Impact factor: 3.000

2.  Reflex epicardial coronary vasoconstriction elicited by nicotine in anaesthetized dogs.

Authors:  C G Sobey; G J Dusting; O L Woodman
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-04       Impact factor: 3.000

Review 3.  Regulation of Coronary Blood Flow.

Authors:  Adam G Goodwill; Gregory M Dick; Alexander M Kiel; Johnathan D Tune
Journal:  Compr Physiol       Date:  2017-03-16       Impact factor: 9.090

4.  Coronary vascular responses to nicotine in the anaesthetized dog.

Authors:  O L Woodman
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-01       Impact factor: 3.000

Review 5.  Neuronal control of coronary blood flow.

Authors:  D Baumgart; G Heusch
Journal:  Basic Res Cardiol       Date:  1995 Mar-Apr       Impact factor: 17.165

6.  Causative role of coronary microvessels for the development and progression of chronic myocardial lesions in spontaneously hypertensive rats (SHR).

Authors:  H J Herrmann; P Mühlig
Journal:  Basic Res Cardiol       Date:  1992 Sep-Oct       Impact factor: 17.165

7.  Enhancement of noradrenergic constriction of large coronary arteries by inhibition of nitric oxide synthesis in anaesthetized dogs.

Authors:  O L Woodman; P Pannangpetch
Journal:  Br J Pharmacol       Date:  1994-06       Impact factor: 8.739

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.